NCT03555591

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,198 (actual)
• Sponsor: Takeda · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this survey is to evaluate the long-term safety and efficacy of trelagliptin tablets in patients with type 2 diabetes mellitus in the routine clinical setting.

Detailed description

The drug being tested in this survey is called trelagliptin tablet. This tablet is being tested to treat people who have type 2 diabetes mellitus. This survey is an observational (non-interventional) study and will look at the long-term safety and efficacy of the trelagliptin tablet in the routine clinical setting. The planned number of observed patients will be approximately 3000. This multi-center observational trial will be conducted in Japan.

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	Trelagliptin	Trelagliptin tablets

Timeline

• Start date: 2016-05-01
• Primary completion: 2021-10-31
• Completion: 2021-10-31
• First posted: 2018-06-13
• Last updated: 2023-12-12
• Results posted: 2023-09-01

Locations

1 site across 1 country: Japan